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 Abstract 
Objective: 
To describe the epidemiology of neonatal infection over the past decade in UK neonatal units. 
Design: 
Retrospective analysis of prospectively collected infection surveillance network data from 2005 to 2014. 
Setting: 
30 neonatal units in the United Kingdom. 
Patients: 
Newborns on participating neonatal units who had a positive blood, cerebrospinal fluid or urine culture and are 
treated with at least five days of appropriate antibiotics. 
Results: 
2,171 episodes of neonatal infection in 1,922 infants were recorded. The incidence of infection was 6.1/1000 
live-births and 48.8/1000 neonatal admissions (2.9 and 23.5 respectively if Coagulase-negative Staphylococci 
(CoNS) cultures excluded). The incidence of infection showed a statistically significant reduction over time with 
reductions in the rates of both early onset sepsis (EOS) and late onset sepsis (LOS). 
The majority of episodes (76%) represented LOS (diagnosed > 48 hours after birth), and infection was more 
common in premature (<37 weeks gestation) and low birth-weight (<2500g) neonates (84% and 81% 
respectively). Commonly identified pathogens included Group B Streptococci (43%) and E.coli (18%) for EOS 
while E.coli (15%), S.aureus (14%) and CoNS were prominent causes of LOS. 
Conclusions: 
This paper describes the epidemiology of neonatal infection in the UK over the past decade. These data enable 
benchmarking of practice and inform areas of future research and guideline development. The results support 
the hypothesis that the introduction of infection prevention care bundles and antibiotic stewardship programmes 
in the UK has reduced the burden of LOS.
 Introduction: 
Neonatal infection is a significant cause of morbidity and mortality in the United Kingdom (UK) and 
worldwide, particularly in low birth-weight (LBW) and preterm infants.1-3 The causative pathogens may change 
over time and between countries.4 
Neonatal infections are classically divided into two distinct clinical syndromes, early onset sepsis (EOS) and 
late onset sepsis (LOS).2,3 This classification guides choices on empiric antimicrobial treatment.5 A 
comprehensive understanding of the epidemiology is essential in order to inform clinical practice and ensure 
adequate empiric antimicrobial coverage of the pathogens encountered.5 
The use of neonatal infection surveillance networks has proved to be a successful method for defining the 
epidemiology of neonatal sepsis in many countries including the USA, Canada, Australia, and Germany.6-9 
There are however, differences in the protocols followed by different surveillance networks; the German7 and 
USA9 networks have focused on VLBW babies cared for in tertiary neonatal units and include both culture 
proven sepsis as well as presumed and possible sepsis. Definitions of sepsis also vary between networks but all 
consist of a combination of clinical and laboratory parameters. Nevertheless such networks provide valuable 
insights into the longitudinal epidemiology of infection, enable benchmarking of practice, and allow assessment 
of the effectiveness and appropriateness of empiric antibiotic prescribing guidelines.4,6,10 Additionally, it has 
been shown that these networks can improve the quality of care within hospitals and reduce rates of infection.7 
neonIN is a neonatal infection surveillance network which was established in 2004 with the objective of 
collecting and storing information about the pathogens which cause neonatal sepsis and their antimicrobial 
resistance patterns on a longitudinal basis. neonIN data from 2006-2008 were published in 2010 and showed an 
infection incidence of 8/1000 live-births (LB) and 71/1000 neonatal-admissions (NA) (4·1 and 38 respectively if 
Coagulase negative Staphylococci (CoNS) excluded).4 
The aim of this analysis was to update these results and describe the epidemiology of neonatal infection over the 
past decade in the neonIN infection surveillance network. 
Methods: 
neonIN collects data on episodes of neonatal infection. An episode of neonatal infection is defined as a positive 
culture collected from a normally sterile site such as the blood, cerebrospinal fluid (CSF) or urine (obtained in a 
sterile manner) for which clinicians prescribed at least five days of appropriate antibiotics. Data are collected 
using a standardised online questionnaire completed by the clinician for each positive culture result. 
Repeatedly positive samples are considered to represent the same episode of infection unless they occurred more 
than seven days after the last positive culture result (or ten days in the case of CoNS or fungal infections). EOS 
is defined as infection occurring less than 48 hours after birth with episodes thereafter being classified as LOS.  
During the study period, 30 neonatal units contributed infection data to the neonIN database. All UK neonatal 
units were able to participate in this network but were required to make a commitment to contribute high quality 
data in a consistent manner. The 30 participating units are based in all parts of England and Wales (see map: 
www.neonin.org.uk) ensuring good geographic representation. 
Neonatal units are designated as local neonatal units (LNUs) (those able to provide full care for neonates more 
than 27 weeks gestation at birth), or neonatal intensive care units (NICUs) (those specialised in caring for the 
sickest and most premature infants), according to the criteria of the British Association of Perinatal Medicine.11 
Data regarding the total number of live-births and neonatal-admissions are collected via the online neonIN 
database. Where denominator data were not entered by a hospital, the figures were extracted from the ‘National 
Neonatal Audit Programme – Annual Report’ of the appropriate year. 11 
Data were extracted and analysed in Stata 14 with statistical significance being defined as a p-value of <0·05. A 
number of statistical tests were used during the analysis process including: 
• Two-sample Student’s t-tests for comparisons of parametric continuous data, 
• Wilcoxon-Mann-Whitney tests for comparisons of non-parametric continuous data, 
• Chi-square tests for comparisons of categorical data if all data were >5 (or Fisher’s exact tests if not), 
• Simple linear regression for analysis of relationships between continuous predictor and outcome 
variables, 
• Simple logistic regression for analysis of relationships between a predictor variable and a binary 
outcome variable. 
Analyses were conducted with and without the inclusion of CoNS, as these are well recognised potential 
contaminants of blood cultures. This is particularly so for EOS cultures as CoNS are believed to be extremely 
unlikely as causative pathogens of EOS. 
The neonIN database received ethics approval from the London-Surrey Borders Research Ethics Committee in 
April 2005 (05/Q0806/34) and this was extended in December 2013 (05/Q0806/34+5) for a period of five years. 
Results: 
Data were extracted for the 10 years between 1 January 2005 and 31 December 2014. The number of UK units 
contributing to neonIN increased over this period with the total number per calendar year being five in 2005 
then eight, nine, 12, 14, 16, 20, 24, 29, and 30 in each subsequent year. Of the participating units, seven (23%) 
were LNUs and 23 (77%) were NICUs. Neonatal surgery was provided in 48% (11/23) of the NICUs. 
All Infections (excluding CoNS) 
A total of 2,171 episodes of neonatal infection were recorded in 1,922 infants over the study period, with 24% 
of cases (n=514) representing EOS. Infection occurred more frequently in male (n=1,089, 57%) than female 
infants (n=833, 43%; p<0·001 (Chi-square test)). Of the 197 infants (10%) to experience more than one episode 
of infection, 74 (38%) did so with the same pathogen. Multiple organisms were isolated from the same culture 
in 4% (n=93) of episodes. 
The majority of cases (n=1,813, 84%) were premature infants (<37 weeks gestation) of whom 87% (n=1,569, 
73% of all cases) were born at less than 32 weeks. Likewise, 81% (n=1,742) of affected infants were LBW 
(<2500g) with 86% (n=1,506, 70% of all cases), 68% (n=1,180, 55%) and 41% (n=717, 33%) of these being 
<1500g (VLBW), <1000g (ELBW) and <750g respectively.  
Insert Figure 1 
Figure 1: Number of episodes of infection caused by the common pathogens of neonatal sepsis in 30 Neonatal 
units in the neonIN network (excluding CoNS infections).  Infections are organised by postnatal age at onset 
(in days) and limited to the neonatal period (28 days). 
The distribution of the most frequently isolated pathogens over the neonatal period is shown in Figure 1. 
The vast majority of episodes were identified by a positive blood culture (n=1,961, 91%). However pathogens 
were isolated from CSF cultures in 41 cases (mean post-natal age = 19 days, 90% (n=37) >48h). The source of 
the remaining pathogens was primarily urine (n=113, 5%) of which 98% were LOS cases with the most 
common pathogens being Candida sp. (n=34, 30%), Enterococcus sp. (n=23, 20%) and E.coli (n=17, 15%). 
The overall incidence of infection (excluding CoNS) was 2·9/1000 live-births (LB) and 23·5/1000 neonatal-
admissions (NA). The highest incidence was found in the surgical units (3·6 and 30·3 respectively). Linear 
regression analysis revealed a statistically significant reduction in the overall incidence of infection by both LBs 
and NAs over the study period (p<0·001 for both). This trend was observed for both LNUs (p=0·005) and 
NICUs with surgery (p<0·001). However NICUs without surgical facilities demonstrated a statistically 
significant increasing trend (p=0·041) (Figure 2). 
Insert Figure 2 
Figure 2: Incidence of infection over the neonIN study period, shown by type of neonatal unit. Incidences 
calculated per 1000 neonatal admissions..  LNU = Local neonatal unit. NICU = Neonatal intensive care unit. 
Early Onset Sepsis 
EOS incidence was 0·7/1000 LBs and 5·6/1000 NAs. A statistically significant downwards trend was noted 
over the study period (p=0·031 (linear regression)) (Figure 2). A large proportion of EOS cases were diagnosed 
in term infants (>37 weeks) (n=213, 42%). Likewise, 50% (n=251) of affected infants weighed >2500g with 
only 32% (n=164) of babies being <1500g (VLBW). 
Of the 514 episodes of EOS, 74% (n=379) were caused by Gram-positive (GP) organisms, 25% (n=130) by 
Gram-negative (GN) organisms and the remaining five cases by Candida sp. (n=4) and Mycobacterium sp. 
(n=1). Group B Streptococcus (GBS) was the most frequently isolated organism (n=221, 43%), while E.coli 
comprised 18% (n=95) of cases. Infants with EOS GBS infection had a median birth-weight of 3026g (IQR = 
2088-3618) and a gestational age at birth of 38 weeks (35-40). 
Comparison of EOS pathogens using 48 and 72 hour cut-offs revealed that there was no significant difference 
between these two thresholds either with respect to individual pathogens (p>0·20 (Chi-square and Fisher-exact 
tests used as appropriate)) or overall (p=0·087) (supplementary table 1). Furthermore, extending the EOS period 
proportionally made the most difference to S.aureus (+27%), a pathogen more commonly associated with LOS, 
and least difference to GBS and Listeria which are both associated with vertical transmission.  
The incidence of EOS GBS over the study period was 0·30/1000 LBs and 2·39/1000 NAs. This increased to 
0·33/1000 LBs when a seven day cut-off for EOS was applied. Over time the EOS GBS incidence demonstrated 
a statistically significant decrease (p=0·004 (linear regression)), falling from 0·45/1000 LBs in 2005 to 0·29 in 
2014. Interestingly, while linear regression revealed a significant decreasing trend in the incidence of premature 
infants with EOS GBS (p=0·046), the incidence in term infants showed no significant trend over time 
(p=0·161). 
Late Onset Sepsis 
The median post-natal age for late-onset infection was 20 days (IQR=10-42 days). The overall incidence of LOS 
over the study period was 2·2/1000 LBs and 17·9/1000 NAs and demonstrated a statistically significant 
downwards trend (p<0·001 (linear regression)) (Figure 2).  
LOS was primarily diagnosed in premature infants (<37 weeks gestation) (n=1,519, 92%) with 91% (n=1,379, 
84% of all cases) of these occurring in those <32 weeks. Similarly, 90% (n=1,487) of affected infants were 
LBW (<2500g) with 90% (n=1,342, 82% of all cases), 72% (n=1,074, 65%), and 44% (n=654, 40%) of these 
being VLBW, ELBW, and <750g respectively. 
Overall Gram positive (GP) organisms accounted for 45% of the 1,657 cases of LOS (n=751) with Gram 
negatives (GN) making up 45% (n=748), and fungi the remaining 10% (n=158). S.aureus was the most 
commonly isolated GP pathogen (n=233, 31%), while E.coli was the most frequent GN (n=241, 32%) and 
C.albicans the most prevalent fungus (n=100, 63%) (Table 1). 
Insert Table 1 
CoNS Infections 
There were 2,408 episodes of CoNS infection involving 2,169 infants. The overall incidence of infection 
(including CoNS) over the study period was 6·1/1000 LBs and 48·8/1000 NAs.  
The majority of CoNS episodes presented as LOS (93%, n=2,233), representing 57% of all recorded LOS cases. 
CoNS infection primarily occurred in extremely premature (<32 weeks) and ELBW infants (83% and 62% 
respectively) (p<0·001 for both (Chi-square tests)), and was isolated almost exclusively from the blood (98%). 
Age at Disease by Pathogen 
Roughly a quarter of all neonatal infections represented EOS with the vast majority of these (76%) occurring on 
the first day of life. EOS infection was highly associated with a birth-weight of >1500g or a gestational-age of 
>32 weeks (69% and 63% respectively) (p<0·001 for both (Chi-square tests)), whereas the vast majority of 
cases of LOS occurred in infants <1500g (82%) and <32 weeks (83%) (p<0·001 for both). These associations 
with gestation and birth-weight became stronger the later the onset of infection (p<0.001 for both (linear 
regression analyses)) (Figure 3). 
Insert Figure 3 
Figure 3: Proportion of infections occurring in neonates <1500g in 30 Neonatal units in the neonIN 
network. Shown by day of infection over the neonatal period (28 days).  
The age at disease was not influenced by gender (p=0·74), but varied significantly by pathogen. GBS had a peak 
incidence on the first day of life (day 0), while E.coli demonstrated two peaks between days 0-3 and 5-10. 
S.aureus demonstrated a broad peak between days 6-12, while Enterobacteriaceae and Enterococcus sp. 
followed no distinct patterns (Figure 4).  
Insert Figure 4 
Figure 4: Incidences of common pathogens causing infections in 30 Neonatal units in the neonIN network. 
by postnatal age. Limited to the neonatal period (28 days). 
Discussion: 
This study shows that preterm and VLBW infants carry the highest burden of infection, particularly LOS. These 
results are consistent with the existing literature.3,4,12,13 Infection was also significantly more common amongst 
males (56%), an association which has been well described.1,4 The reason for this association remains unclear 
but likely reflects the preponderance of male gender among preterm births in general.14 
Comparisons can be made between the neonIN-derived data and those of several other studies from the UK and 
internationally. A single-centre study by Haque et al.15 reported a comparable incidence of neonatal infection 
while a laboratory surveillance programme throughout England and Wales reported a similar distribution of 
pathogens.16 Comparisons with previous neonIN analyses reveal a slightly lower incidence of infection in the 
current study and a similar pathogen distribution.4 The increased proportion of NICUs in the early years of the 
neonIN database as well as the decreasing overall incidence of infection are two factors which may explain this 
discrepancy. For these reasons the data in this study supersede those previously published. 
US and Australian studies report consistently higher rates of E.coli and fungal infections, although this is 
partially compensated by lower rates of GBS and CoNS.8,17-20 It is possible that much of this difference relates 
to different approaches to GBS screening and intrapartum antibiotic prophylaxis (IAP) use in these 
countries.4,8,17,20 Comparisons of LOS incidence with that of the German NeoKISS21 system reveal similar 
incidences of infection among VLBW infants and a similar distribution of pathogens; although overall Neo-
KISS demonstrates a higher prevalence of S.aureus and Enterobacter sp. and a lower prevalence of E.coli and 
Enterococcus sp. than neonIN.21 This reinforces the necessity of having local surveillance networks for 
informing clinical practices and optimising neonatal care. 
There was a decreasing trend in the overall incidence of infection (p<0·001). This was accounted for by 
decreases in the rates of both LOS (p<0·001) and EOS (p=0·031). It is possible that the decreasing trend in LOS 
is the result of implementation and adherence to programmes focusing on the prevention of late-onset hospital 
acquired infections; a significant initiative in UK healthcare facilities over the past decade.22,23 Not all European 
neonatal units have seen such a decline however, leading to a call for greater adherence to interventions 
including hand-hygiene policies and central-line care bundles.22-25 
EOS reflects vertical transmission of maternal pathogens and its incidence will be affected by other factors.1 The 
major pathogen that contributes to EOS is GBS and a statistically significant downward trend was noted in its 
incidence over the study period (p=0·035).1,26 This might reflect the introduction of risk-based IAP protocols in 
the UK in 2003.20,27,28 As neonIN only includes infants admitted to neonatal units, any impact may be limited to 
premature infants with GBS, who form a minority of the total burden of GBS disease. This hypothesis is 
supported by the fact that neonIN infants with EOS GBS had a lower median birth-weight and gestational-age 
(3026g and 38 weeks) than those in the recent national surveillance study (3300g and 39 weeks).29 The 
decreasing incidence in preterm but not term infants is also consistent with the findings of this study and may 
reflect a tendency for clinicians to particularly target IAP towards certain groups of preterm births, as 
recommended in the recent National Institute of Health and Care Excellence antibiotic for early onset infection 
guidelines.30 
The reduction of infection incidence was not seen in all unit types but only in the LNUs (p=0·005), and the 
NICUs with surgical facilities (p=0·001). NICUs without surgery demonstrated an increased incidence over the 
same period (p=0·041). These opposing trends are intriguing and require further analysis; one possible 
explanation is the transition of the UK hospital system to a ‘network-based’ system from 2004-2007.31 This 
resulted in reduced neonatal admissions of infants <27 weeks in LNUs and a corresponding increase in 
admission rates of these very premature babies to the associated NICUs within the same networks.31 This 
hypothesis may be supported by the observation that there was a trend towards a reduction in the proportion of 
infants <27 weeks gestation in LNUs over the study period (p=0·083). 
Debate exists over what represents the most appropriate cut-off point for EOS, with 48 and 72 hours the most 
commonly used alternatives.4,10 This study found no statistically significant increase in the pathogens captured 
by a 72 hour cut-off when compared to 48 hours. The validity of a 48 hour cut-off is also shown by the finding 
that the majority of pathogens observed between 48 and 72 hours were those normally associated with 
horizontal (nosocomial) transmission (e.g. S.aureus and Enterococci).4,5 Furthermore GBS, the commonest EOS 
pathogen and one known to be vertically transmitted, displayed the smallest proportional increase.27,28  
The primary strength of the neonIN database is its size and longitudinal design. A number of limitations of this 
study however must also be acknowledged. Firstly, the infection definition may be considered too simplistic or 
subjective given its reliance on the clinician’s judgement that a treatment course should be given. This 
subjectivity may lead to over-reporting of cases, particularly of common skin contaminants such as CoNS. An 
alternative would be to incorporate more clinical and laboratory markers into the study definition, but it is 
essential that the infection definition remains simple or it will affect the completeness and quality of the data 
entered. Data completeness is another potential limitation of neonIN as it relies on voluntary reporting of 
infection episodes by hospital staff.6 
This study provides unique insights into the epidemiology of infectious diseases in neonates in the UK. It 
describes the incidence of infection in UK neonatal units and the relative prevalence of the causative pathogens. 
The results support the hypothesis that the introduction of infection prevention care bundles and antibiotic 
stewardship programmes in the UK has reduced the burden of LOS. These data inform areas of future research 
and guideline development which work towards addressing better health outcomes in our neonatal populations.
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 Pathogen Number Percentage 
Gram Positive 2,984 77% 
 Coagulase Negative Staphylococci 2,233 75% 
 Staphylococcus aureus 233 8% 
 Enterococcus faecalis 184 6% 
 Group B Streptococci 136 5% 
 Enterococcus (other) 71 2% 
 Streptococcus (other) 38 1% 
 Micrococcus sp. 25 1% 
 Bacillus sp. 24 1% 
 Diphtheroids 11 <1% 
 Beta Haemolytic Streptococci 9 <1% 
 Alpha Haemolytic Streptococci 7 <1% 
 Enterococcus faecium 7 <1% 
 Streptococcus pneumoniae 3 <1% 
 Propionibacterium acnes 2 <1% 
 Listeria monocytogenes 1 <1% 
Gram Negative 748 19% 
 E.coli 241 32% 
 Klebsiella sp. 160 21% 
    Klebsiella pneumoiae 66 41% 
    Klebsiella oxytoca 55 34% 
    Klebsiella aerogenes 18 11% 
    Klebsiella sp. (undefined) 21 13% 
 Enterobacter sp. 136 18% 
    Enterobacter cloacae 102 75% 
    Enterobacter aerogenes 16 12% 
    Enterobacter sp. (undefined) 18 13% 
 Pseudomonas sp. 73 10% 
    Pseudomonas aeruginosa 66 91% 
    Pseudomonas cepacia 1 1% 
    Pseudomonas stutzeri 1 1% 
    Pseudomonas sp. (undefined) 5 7% 
 Serratia sp. 43 6% 
    Serratia marcescens 38 88% 
    Serratia liquefaciens 1 2% 
    Serratia sp. (undefined) 4 10% 
 Coliform 26 3% 
 Acinetobacter sp. 25 3% 
    Acinetobacter baumanii 6 24% 
    Acinetobacter anitratus 1 4% 
    Acinetobacter lwoffii 1 4% 
    Acinetobacter sp. (undefined) 17 68% 
 Citrobacter sp. 13 2% 
 Burkholderia sp. 5 <1% 
 Haemophilus sp. 5 <1% 
 Morganella morganii 5 <1% 
 Moraxella catarrhalis 4 <1% 
 Proteus sp. 3 <1% 
 Providencia stuartii 3 <1% 
 Stenotrophomonas maltophilia 3 <1% 
 Neisseria sp. 1 <1% 
 Pantoea 1 <1% 
 Salmonella sp. 1 <1% 
Fungi 158 4% 
 Candida sp. 151 96% 
   Candida albicans 100 66% 
   Candida parapsilosis 19 13% 
   Candida tropicalis 2 1% 
   Candida glabrata 2 1% 
   Candida guilliermondii 1 <1% 
   Candida dubliniensis 1 <1% 
   Candida sp. (undefined) 26 17% 
 Yeasts 5 3% 
 Aspergillus fumigatus 1 <1% 
 Malassezia furfur 1 <1% 
 
Table 1: Causative pathogens of late onset sepsis found in 30 UK Neonatal units in the neonIN network. 
Total number and percentage composition of recorded positive cultures for all recorded late onset sepsis 
pathogens. 
 Associated ‘Boxes’ of Background Information 
What is already known on this topic: 
• Neonatal infection is an important cause of morbidity and mortality, particularly in low birth-
weight and preterm infants. 
• A comprehensive and up to date understanding of the epidemiology of infection is essential 
as it may change over time and differ between countries. 
• Neonatal infection surveillance networks have been successfully established in multiple 
countries and are used to benchmark practice, establish prescribing guidelines and improve 
quality of care. 
What this study adds: 
• The incidence of neonatal infection in Neonatal units the UK has declined over the past 
decade. 
• This decline suggests an impact of interventions such as central-line care bundles and 
intrapartum antibiotic prophylaxis guidelines. 
• This decline was not seen in Neonatal Intensive Care Units without surgical facilities. 
 
 
 
 
 
